Loading...

Aurora Cannabis Inc.

ACB•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.54
$0.07(1.57%)

Aurora Cannabis Inc. (ACB) Stock Overview

Explore Aurora Cannabis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.8/100

Key Financials

Market Cap255.4M
P/E Ratio208.67
EPS (TTM)$0.19
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Week$5.51
1 Month$4.47
3 Months$0.00
1 Year Target$1.92

ACB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aurora Cannabis Inc. (ACB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 208.67 and a market capitalization of 255.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
15.86%
↑ 15.86%
Profit Growth
$0.03
↑ 73.87%
EPS Growth
$0.03
↑ 95.09%
Operating Margin
1.44%
↑ 81.73%
ROE
0.28%
↑ 73.87%
Dividend Yield
0.00%
Analyst Recommendations data is not available for ACBAnalyst Recommendations details for ACB are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

CEO

Miguel Martin

Employees

1,073

Headquarters

500 - 10355 Jasper Avenue, Edmonton, AB

Founded

2014

Frequently Asked Questions

;